Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Oxytocin misuse: CDSCO...

    Oxytocin misuse: CDSCO calls manufacturers for discussion

    Written by Ruby Khatun Khatun Published On 2018-02-20T15:15:14+05:30  |  Updated On 20 Feb 2018 3:15 PM IST
    Oxytocin misuse: CDSCO calls manufacturers for discussion

    New Delhi: Through a notification dated 16th Feb 2018, Central Drugs Standard Control Organization (CDSCO) has called all the Manufacturers of Oxytocin Formulation for human and animal use for meeting on 22nd February 2018 at 11.00 AM at Malviva Bhawan, Deen Dayal Upadhyaya Marg, New Delhi to discuss issues related to misuse of Oxytocin.


    The notice states that the reports have appeared from time to time in various fora about the misuse of Oxytocin in the country by the farmers and dairy owners to extract milk from milch animals.


    Cases of illegal manufacture, import and sale of the drug and its misuse by the farmers or dairy owners have also been unearthed from time to time in different parts of the country.


    Various measures have been taken by CDSCO and Ministry of Health and Family Welfare, Govt. of India to curb such misuse of the drug.


    Read also: Concerned about Oxytocin misuse, CDSCO to outline regulatory control

    In this regard, a meeting of all manufacturers of Oxytocin formulation for human and animal use, with CDSCO has been convened on 22nd February 2018 at 11.00 AM at Malviva Bhawan, Deen Dayal Upadhyaya Marg, New Delhi to discuss the matter for taking appropriate measures to prevent the misuse of Oxytocin.


    CDSCO has requested manufacturers to make it convenient to depute one representatives to attend the meeting. A line of confirmation in the Email: dciai.nic.in shall be appreciated.


    Oxytocin is a hormonal injection that is used widely in the dairy industry, agriculture and horticulture to boost milk production and increase the size of vegetables.


    Oxytocin is a uterine stimulant hormone, prescribed for the initiation of uterine contractions and induction of labour in women as well as stimulation of contractions during labour. It is also used to help abort the fetus in cases of incomplete abortion or miscarriage, and control bleeding after childbirth. It may be used for breast engorgement.


    Studies have shown that Oxytocin is being misused to speed up deliveries for pregnant women in overcrowded government hospitals. The drug has been under scrutiny for long, with its retail sale by pharmacies already banned.


    Oxytocin is listed on the National List of Essential Medicines (NLEM) for reproductive health. In India, it’s available under various brand names and many large Indian companies manufacture its formulation like Hemmo Pharmaceutical Pvt. Ltd, Pfizer Ltd, Cadila Healthcare Ltd and Troikaa Pharmaceuticals Ltd.


    Below is the attachment for the same.

    http://www.cdsco.nic.in/writereaddata/Oxytocin 18meeting notice.pdf
    CDSCOCentral Drugs Standard Control OrganizationmanufacturersMinistry of Health and Family WelfareMisuseOxytocinOxytocin Formulation

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok